Stagezero Life Sciences Stock Analysis
| SZLSF Stock | USD 0.0005 0.00 0.00% |
StageZero Life Sciences holds a debt-to-equity ratio of 0.946. StageZero Life's financial risk is the risk to StageZero Life stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
StageZero Life's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. StageZero Life's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps StageZero Pink Sheet's retail investors understand whether an upcoming fall or rise in the market will negatively affect StageZero Life's stakeholders.
For many companies, including StageZero Life, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for StageZero Life Sciences, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, StageZero Life's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that StageZero Life's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which StageZero Life is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of StageZero Life to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, StageZero Life is said to be less leveraged. If creditors hold a majority of StageZero Life's assets, the Company is said to be highly leveraged.
StageZero Life Sciences is fairly valued with Real Value of 4.8E-4 and Hype Value of 5.15E-4. The main objective of StageZero Life pink sheet analysis is to determine its intrinsic value, which is an estimate of what StageZero Life Sciences is worth, separate from its market price. There are two main types of StageZero Life's stock analysis: fundamental analysis and technical analysis.
The StageZero Life pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and StageZero Life's ongoing operational relationships across important fundamental and technical indicators.
StageZero |
StageZero Pink Sheet Analysis Notes
The book value of the company was at this time reported as 0.01. The company recorded a loss per share of 0.01. StageZero Life Sciences last dividend was issued on the 18th of September 2020. The entity had 1:8 split on the 18th of September 2020. StageZero Life Sciences Ltd., a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in the United States and Canada. The company was founded in 1998 and is headquartered in Richmond Hill, Canada. Stagezero Life operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 80 people.The quote for StageZero Life Sciences is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about StageZero Life Sciences learn more at https://www.stagezerolifesciences.com.StageZero Life Sciences Investment Alerts
| StageZero Life generated a negative expected return over the last 90 days | |
| StageZero Life has high historical volatility and very poor performance | |
| StageZero Life has some characteristics of a very speculative penny stock | |
| StageZero Life Sciences has accumulated 582.46 K in total debt with debt to equity ratio (D/E) of 0.95, which is about average as compared to similar companies. StageZero Life Sciences has a current ratio of 0.13, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist StageZero Life until it has trouble settling it off, either with new capital or with free cash flow. So, StageZero Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like StageZero Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for StageZero to invest in growth at high rates of return. When we think about StageZero Life's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 5.07 M. Net Loss for the year was (7.48 M) with profit before overhead, payroll, taxes, and interest of 1.18 M. | |
| StageZero Life Sciences has accumulated about 90.63 K in cash with (8.95 M) of positive cash flow from operations. |
StageZero Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.39 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate StageZero Life's market, we take the total number of its shares issued and multiply it by StageZero Life's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.StageZero Profitablity
The company has Profit Margin (PM) of (0.91) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.99) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.99.Technical Drivers
As of the 9th of February, StageZero Life has the Coefficient Of Variation of (800.00), variance of 127.11, and Risk Adjusted Performance of (0.09). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of StageZero Life Sciences, as well as the relationship between them. Please validate StageZero Life Sciences mean deviation and treynor ratio to decide if StageZero Life is priced more or less accurately, providing market reflects its prevalent price of 5.0E-4 per share. As StageZero Life Sciences appears to be a penny stock we also recommend to double-check its information ratio numbers.StageZero Life Sciences Price Movement Analysis
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Weighted Moving Average calculates a weight for each value in StageZero Life price series with the more recent values given greater weights.
StageZero Life Predictive Daily Indicators
StageZero Life intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of StageZero Life pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 5.0E-4 | |||
| Day Typical Price | 5.0E-4 |
StageZero Life Forecast Models
StageZero Life's time-series forecasting models are one of many StageZero Life's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary StageZero Life's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.StageZero Life Sciences Debt to Cash Allocation
Many companies such as StageZero Life, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
StageZero Life Sciences has accumulated 582.46 K in total debt with debt to equity ratio (D/E) of 0.95, which is about average as compared to similar companies. StageZero Life Sciences has a current ratio of 0.13, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist StageZero Life until it has trouble settling it off, either with new capital or with free cash flow. So, StageZero Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like StageZero Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for StageZero to invest in growth at high rates of return. When we think about StageZero Life's use of debt, we should always consider it together with cash and equity.StageZero Life Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the StageZero Life's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of StageZero Life, which in turn will lower the firm's financial flexibility.About StageZero Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how StageZero Life prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling StageZero shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as StageZero Life. By using and applying StageZero Pink Sheet analysis, traders can create a robust methodology for identifying StageZero entry and exit points for their positions.
StageZero Life Sciences Ltd., a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in the United States and Canada. The company was founded in 1998 and is headquartered in Richmond Hill, Canada. Stagezero Life operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 80 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding StageZero Life to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Premium Stories Now
Premium StoriesFollow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
| All Next | Launch Module |
Complementary Tools for StageZero Pink Sheet analysis
When running StageZero Life's price analysis, check to measure StageZero Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy StageZero Life is operating at the current time. Most of StageZero Life's value examination focuses on studying past and present price action to predict the probability of StageZero Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move StageZero Life's price. Additionally, you may evaluate how the addition of StageZero Life to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |